FORM 8-K

Company

REVIVA PHARMACEUTICALS HOLDINGS, INC.

Filed

September 26, 2025

Period of Report

September 26, 2025

Accession Number

0001437749-25-029951

An 8-K is a current report used to announce material events that shareholders should know about — such as earnings releases, mergers, executive changes, or bankruptcy. Learn more about 8-K filings →